BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2840461)

  • 1. Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP.
    Farrar WL; Vinocour M; Cleveland JL; Harel-Bellan A
    J Immunol; 1988 Aug; 141(3):967-71. PubMed ID: 2840461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
    Shurtleff SA; McElwain CM; Taffet SM
    J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL; Evans SW; Rapp UR; Cleveland JL
    J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid growth factor(s) regulation of ornithine decarboxylase: effects of antiproliferative signals interferon-gamma and cAMP.
    Farrar WL; Harel-Bellan A
    Blood; 1989 May; 73(6):1468-75. PubMed ID: 2469492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
    Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
    J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase activation and the immunosuppressant cyclosporine.
    Fidelus RK; Laughter AH
    Transplantation; 1986 Feb; 41(2):187-92. PubMed ID: 3003975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of competence in resting B cells. The induction of cyclic AMP and ornithine decarboxylase activity after direct contact between B and T helper cells.
    Pollok KE; O'Brien V; Marshall L; Olson JW; Noelle RJ; Snow EC
    J Immunol; 1991 Mar; 146(5):1633-41. PubMed ID: 1847169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
    Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 induces ornithine decarboxylase in normal T lymphocytes.
    Bristol LA; Smith MR; Bhat NK; Durum SK
    J Immunol; 1991 Mar; 146(5):1509-15. PubMed ID: 1993840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Pong RC; Erickson D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6149-55. PubMed ID: 3779635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial lipopolysaccharide induction of ornithine decarboxylase in the macrophage-like cell line RAW264: requirement of an inducible soluble factor.
    Taffet SM; Haddox MK
    J Cell Physiol; 1985 Feb; 122(2):215-20. PubMed ID: 2578474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new perspective on ornithine decarboxylase regulation: prevention of polyamine toxicity is the overriding theme.
    Morris DR
    J Cell Biochem; 1991 Jun; 46(2):102-5. PubMed ID: 1918176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells.
    Lichti U; Gottesman MM
    J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.